TY - JOUR
T1 - A pilot study of intensive intervention using a novel trismus device
AU - Charters, Emma
AU - Cheng, Kai
AU - Dunn, Masako
AU - Wu, Raymond
AU - Palme, Carsten
AU - Howes, Dale
AU - Low, Tsu-Hui (Hubert)
AU - Heng, Caleb
AU - Ricketts, Virginia
AU - Kneebone, Karri
AU - Loy, Jamie
AU - Clark, Jonathan R.
PY - 2023/12
Y1 - 2023/12
N2 - Purpose: Trismus secondary to head and neck neoplasm treatment impacts upon quality of life, nutrition, oral hygiene, and dentition. Current treatment options for trismus apply unquantified force to the jaw, and in many cases, the device costs are prohibitive. This study aimed to prospectively evaluate the impact of a novel trismus device. Method: This single arm cohort study prospectively evaluated the impact of a novel trismus device on maximal incisal opening (MIO), trismus-related function and quality of life scores. Seventeen patients diagnosed with trismus were recruited to undergo a 10-week program using a novel device. The effect of the intervention was assessed by comparing pre- vs post-intervention validated measures. Result: A significant improvement in MIO was observed post the 10-week intervention period (12.6 mm). This was associated with an improvement in patient reported trismus symptomology including quality of life, swallowing, speech, and jaw pain. Conclusions: This pilot study demonstrates the feasibility of a novel device in the treatment of trismus. Further evaluation of this device is warranted to assess efficacy, safety, and cost-effectiveness in a larger cohort with appropriate controls.
AB - Purpose: Trismus secondary to head and neck neoplasm treatment impacts upon quality of life, nutrition, oral hygiene, and dentition. Current treatment options for trismus apply unquantified force to the jaw, and in many cases, the device costs are prohibitive. This study aimed to prospectively evaluate the impact of a novel trismus device. Method: This single arm cohort study prospectively evaluated the impact of a novel trismus device on maximal incisal opening (MIO), trismus-related function and quality of life scores. Seventeen patients diagnosed with trismus were recruited to undergo a 10-week program using a novel device. The effect of the intervention was assessed by comparing pre- vs post-intervention validated measures. Result: A significant improvement in MIO was observed post the 10-week intervention period (12.6 mm). This was associated with an improvement in patient reported trismus symptomology including quality of life, swallowing, speech, and jaw pain. Conclusions: This pilot study demonstrates the feasibility of a novel device in the treatment of trismus. Further evaluation of this device is warranted to assess efficacy, safety, and cost-effectiveness in a larger cohort with appropriate controls.
KW - deglutition disorders
KW - dysphagia
KW - head and neck neoplasm
KW - Trismus
UR - http://www.scopus.com/inward/record.url?scp=85144153294&partnerID=8YFLogxK
U2 - 10.1080/17549507.2022.2130429
DO - 10.1080/17549507.2022.2130429
M3 - Article
C2 - 36511636
AN - SCOPUS:85144153294
SN - 1754-9507
VL - 25
SP - 813
EP - 820
JO - International Journal of Speech-Language Pathology
JF - International Journal of Speech-Language Pathology
IS - 6
ER -